When a pandemic appears in the world, people start to worry about whether or not they will be affected by the disease. Questions arise like: What are the chances of it spreading? Are there vaccines? Pandemics like the H5N1 avian flu in 2004, the H1N1 flu virus in 2009, and most recently the Ebola epidemic in West Africa have brought about these types of questions. Most often, when an epidemic breaks out, there is not a common vaccine or cure right away. Texas A&M University is in the process of designing a new Pandemic Influenza Vaccine Manufacturing Facility expected to be operational in 2017.Read More
Science Market Update
In 2010, the Macondo well in the Gulf of Mexico blew-out, leading to the largest off-shore oil spill in the United States, known as the Deepwater Horizon Oil Spill, or the BP Oil Spill. 4.9 million barrels of oil are estimated to have gushed into the Gulf waters during this time, causing an immense impact on the ecosystem in the Gulf. Now, 4 years after the spill, the Gulf of Mexico is still greatly impacted and affected by the oil left in the water. Researchers at the University of Georgia, Athens recently received $18.8 million to continue their study of the impacts of this oil spill on the ecosystem.Read More
Researchers at the Icahn School of Medicine at Mount Sinai University in New York have been studying how stress on fetal development is affected by different environmental toxins. The National Institute of Environmental Health Sciences (NIEHS) recently awarded Mount Sinai professor and researcher Manish Arora, BDS, PhD, MPH a $1.5 million New Innovator Award to help him continue this research. (Image on left courtesy of Wikipedia)Read More
Combining scientific disciplines to tackle a common problem can be very powerful. In broad terms, biology benefits greatly from the processing and computational prowess of computer science and the molecular studies of chemistry. At the University of Wisconsin, Madison, a cross-disciplinary team is breaking the standard notions of tumor ablations.Read More
Do you have lab products that you want to market to life science researchers? Are you interested in meeting with hundreds of active researchers to sell your lab equipment? If you answered yes to either of these questions, consider attending the 2015 39th Semiannual Biotechnology Vendor Showcase™ at the University of California San Diego in February!
Attending a Biotechnology Vendor Showcase™ at UCSD gives YOU the chance to meet with nearly 500 active life science researchers in need of new lab equipment to help with their work. The event is located on campus, as close to the research labs as possible, making it convenient for the researchers to take a break from their work to come visit the show and discover the best and newest products and technologies that will help move their work forward.Read More
Microbes, also known as germs, are found everywhere in the human body. Some are bad for health, some are good, and some still have unknown purposes. When the germs in the body cause an illness to set in, it is common to take antibiotic drugs to fight off the bad microbes making you sick. There are hundreds of types of antibiotics that cure different infections, but one thing all these antibiotics have in common is that they kill off all microbes, both good and bad. Life science researchers at Rockefeller University in New York have been working on creating 'programmable' antibiotics that will be able to target specific germs instead of attacking all of them.Read More
Exxon Mobil, the most traded international oil and gas company in the world, donates millions of dollars annually to community organizations that work with the sciences, health and education. The company, which has headquarters in both Irving and Houston, Texas, has a long history of helping out local Texas organizations. Keeping with its commitment to working in Texas, Exxon Mobil recently announced that it will donate $18 million to three research institutions located within the Texas Medical Center in Houston.Read More
Researchers at Washington University in St. Louis have received an immense amount of additional funding from the National Institute on Aging to assist them on the first large-scale clinical trial to study Alzheimer's disease that is underway. This clinical trial, called the Dominantly Inherited Alzheimer’s Network Trials Unit (DIAN-TU) will work with people who have dominantly inherited forms of Alzheimer's to identify new drugs that can slow the onset of the disease, or stop it altogether.
Beginning with $5.5 million in funding this year, the trial will continue to receive funding from the NIH over the next five years to total $26 million. The National Institute of Aging has been supporting this research since 2012, when the project began. This new funding will allow the trial to add an additional 300-400 participants to the study, as well as assist the research team in adding new drugs to the study. The trial is being run in locations in the United States, Canada, Europe, and Australia, and this funding will help add 10-15 more locations.Read More
In the process of growing and studying neurons in the lab, life science researchers often use flat platforms or dishes. But neural networks in the body don’t lie on a flat plane or platform. A research team from the University of Illinois, Urbana-Champaign decided to add a new dimension to neuron study by developing a 3D environment to study neural networks.Read More